Menu

Pharmacology Procurement Transformation for Life Sciences

Pharmacology Procurement Transformation for Life Sciences
Pharmacology Procurement Transformation for Life Sciences

Home ›
Insights ›
Pharma ›
Pharmacology Procurement Transformation for Life Sciences

Author:
Aykut Cakir · NMS Consulting

Published:
• Updated:

Quick Answer:
Build a clean spend baseline, protect GMP and traceability, and run focused sourcing waves across APIs, packaging, CMOs, CROs, logistics, and indirect. Use quality agreements, supplier qualification, and DSCSA checks while delivering savings and service gains in ninety days.

Want a pharma spend cube, sourcing wave plan, and quality guardrails?
Talk to a consultant

Signals and Guardrails

  • DSCSA requires interoperable package-level traceability and Authorized Trading Partner checks in the U.S. drug supply chain. source
  • Written quality agreements clarify roles in contract manufacturing subject to CGMP. source
  • ICH Q7 defines GMP for APIs and supplier expectations that affect sourcing and audits. source
  • EU GDP guidance frames distribution and serialization responsibilities for EEA flows. source
  • Data and AI raise procurement impact when paired with a solid data foundation and use-case focus. source
  • Life sciences supply chains are prioritizing resilience, digital tools, and cost control. source

30-60-90 Procurement Playbook

First 30 Days: Baseline, Guardrails, and Wave Design

  • Build the spend cube and supplier map across APIs, excipients, packaging, CMOs, CROs, logistics, lab supplies, and indirect.
  • Confirm quality agreements for CMOs and critical suppliers. Align roles, testing, and change control. reference
  • Verify DSCSA obligations and trading partner status for affected flows. reference

Days 31 to 60: Sourcing Waves and Early Savings

  • Run competitive events and negotiations for priority categories. Harmonize rate cards and terms where contracts allow.
  • Add analytics for price variance, should-cost, lead time, and supplier performance to the sourcing cockpit. reference
  • Tighten inbound quality checks and OTIF tracking across sites.

Days 61 to 90: Scale, Risk, and Supplier Management

  • Dual-source critical APIs and packaging where feasible. Keep API suppliers aligned to ICH Q7. reference
  • Stand up supplier scorecards with quality metrics, OTIF, and cost-to-serve. Hold quarterly reviews for CMOs and CROs. reference
  • Bake DSCSA data checks and CAPA follow up into handoffs with sites and partners. reference

Category Levers and Metrics

Category, Levers, Metrics, and Key Guardrails
Category Levers Metrics Guardrails
APIs and Excipients Dual-source, volume tiers, should-cost, MOQ and lead time resets Price variance vs index, OTIF, right-first-time, deviation rate ICH Q7 alignment, change control, supplier qualification
CMOs and Fill-Finish Rate card harmonization, slotting rules, shared validation plans Throughput, cycle time, batch release success, service level Quality agreements, audit schedule, CAPA tracking
Clinical and CRO Panel strategy, volume commits, deliverable-based fees On-time milestones, query turnaround, cost per patient Data integrity, protocol change control
Packaging and Serialization Spec rationalization, vendor consolidation, price ladders Scrap rate, artwork cycle time, OTIF DSCSA data exchange, label accuracy
Labs and QC Standard kits, service contracts, volume rebates Turnaround time, OOS rate, consumables per batch Method validation, instrument qualification
Indirect and IT Tooling rationalization, catalog discipline, p-card policy Contract coverage, compliance, cycle time Access control, data retention

Frequently Asked Questions

How Do We Balance Savings With GMP and Supply Risk?

Segment suppliers, keep critical items dual-sourced, and use scorecards that include cost, quality, and delivery. Keep quality agreements current and make change control part of every award. reference

What Data Platform Do We Need for Sourcing?

Start with a clean spend baseline and a simple analytics layer for variance, should-cost, lead time, and supplier performance. Add quick wins, then expand the model and workflows. reference

What DSCSA Checks Matter in Procurement?

Confirm trading partner status, serialization data exchange, and data retention across packaging and distribution flows tied to affected products. reference

Want a Pharma Sourcing Wave Plan? We can deliver a spend cube, quality guardrails, and a ninety day sourcing program that finance can track.

Request a workshop

Sources

  • FDA. Drug Supply Chain Security Act. https://www.fda.gov/drugs/drug-supply-chain-integrity/drug-supply-chain-security-act-dscsa
  • FDA. Quality Agreements for Contract Manufacturing. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/contract-manufacturing-arrangements-drugs-quality-agreements-guidance-industry
  • ICH. Q7 GMP for Active Pharmaceutical Ingredients. https://database.ich.org/sites/default/files/Q7%20Guideline.pdf
  • European Commission. GDP Guidelines for Medicinal Products. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=oj%3AJOC_2013_343_R_0001_01
  • McKinsey. Data and AI in Procurement. https://www.mckinsey.com/capabilities/operations/our-insights/revolutionizing-procurement-leveraging-data-and-ai-for-strategic-advantage
  • Deloitte. Life Sciences Supply Chain and Manufacturing. https://www.deloitte.com/us/en/Industries/life-sciences-health-care/articles/life-sciences-supply-chain-manufacturing.html
  • FDA. Quality Metrics for Drug Manufacturing. https://www.fda.gov/drugs/pharmaceutical-quality-resources/quality-metrics-drug-manufacturing
  • FDA. Corrective and Preventive Actions. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/inspection-guides/corrective-and-preventive-actions-capa




About the Author

Aykut Cakir

Aykut Cakir

Aykut Cakir, Senior Partner and Chief Executive Officer, has a demonstrated history in negotiations, business planning, business development. He has served as a Finance Director for gases & energy, pharmaceuticals, retail, FMCG, and automotive industries. He has collaborated closely with client leadership to co-create a customized operating model tailored to the unique needs of each project segment in the region. Aykut conducted workshops focused on developing effective communication strategies to ensure team alignment with new operating models and organizational changes. 

 

 

Related Posts